An Examination of Cognitive Fatigue Using Functional Neuroimaging
Latest Information Update: 06 Mar 2024
At a glance
- Drugs Ozanimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 28 Feb 2024 Planned End Date changed from 1 Aug 2023 to 1 Dec 2024.
- 28 Feb 2024 Planned primary completion date changed from 1 Aug 2023 to 1 Dec 2024.
- 28 Feb 2024 Status changed from not yet recruiting to recruiting.